Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Kinder Morgan (EP-PC) Cash & Equivalents (2016 - 2025)

Kinder Morgan's Cash & Equivalents history spans 16 years, with the latest figure at $63.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 28.41% year-over-year to $63.0 million; the TTM value through Dec 2025 reached $63.0 million, down 28.41%, while the annual FY2025 figure was $63.0 million, 28.41% down from the prior year.
  • Cash & Equivalents reached $63.0 million in Q4 2025 per EP-PC's latest filing, down from $71.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.4 billion in Q1 2021 to a low of $63.0 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $359.0 million, with a median of $101.0 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: plummeted 93.9% in 2022, then soared 397.0% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $1.1 billion in 2021, then tumbled by 34.65% to $745.0 million in 2022, then plummeted by 88.86% to $83.0 million in 2023, then grew by 6.02% to $88.0 million in 2024, then fell by 28.41% to $63.0 million in 2025.
  • Per Business Quant, the three most recent readings for EP-PC's Cash & Equivalents are $63.0 million (Q4 2025), $71.0 million (Q3 2025), and $82.0 million (Q2 2025).